{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:45:49Z","timestamp":1791841549539,"version":"4.3.4"},"reference-count":158,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2023IR23"],"award-info":[{"award-number":["2023IR23"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2024IR11"],"award-info":[{"award-number":["2024IR11"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171722"],"award-info":[{"award-number":["82171722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271764"],"award-info":[{"award-number":["82271764"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471772"],"award-info":[{"award-number":["82471772"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.isci.2026.116029","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:33:32Z","timestamp":1780403612000},"page":"116029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor infiltrating B cells and tertiary lymphoid structures in pancreatic cancer prognosis and therapy"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5851-7578","authenticated-orcid":false,"given":"Zichen","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinmo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116029_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.116029_bib2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.116029_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","article-title":"Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer","volume":"160","author":"Huang","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2026.116029_bib4","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.116029_bib5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.isci.2026.116029_bib6","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/SLA.0000000000002734","article-title":"Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma","volume":"269","author":"Groot","year":"2019","journal-title":"Ann. Surg."},{"key":"10.1016\/j.isci.2026.116029_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","article-title":"Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.116029_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2026.116029_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41698-024-00681-z","article-title":"Barriers and opportunities in pancreatic cancer immunotherapy","volume":"8","author":"Ju","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.isci.2026.116029_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12935-025-03668-3","article-title":"Tumor-infiltrating B cells in non-small cell lung cancer: current insights and future directions","volume":"25","author":"Jiang","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.isci.2026.116029_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41423-018-0027-x","article-title":"Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer","volume":"16","author":"Wang","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116029_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.ccell.2021.09.007","article-title":"B cells and cancer","volume":"39","author":"Engelhard","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12967-021-03044-5","article-title":"Associations of immune cell homing gene signatures and infiltrates of lymphocyte subsets in human melanomas: discordance with CD163(+) myeloid cell infiltrates","volume":"19","author":"Kwak","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.116029_bib15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib16","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","article-title":"Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.116029_bib17","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1038\/s41388-022-02425-4","article-title":"BTLA(+)CD200(+) B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer","volume":"41","author":"Diskin","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.116029_bib18","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/bjc.2015.145","article-title":"Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer","volume":"112","author":"Hiraoka","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.116029_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1152551","article-title":"Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies","volume":"14","author":"Senturk","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41423-023-01060-7","article-title":"Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers","volume":"20","author":"Playoust","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.116029_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the Human Immunology Project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.immuni.2020.06.013","article-title":"An Integrated Multi-omic Single-Cell Atlas of Human B Cell Identity","volume":"53","author":"Glass","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116029_bib24","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/1097-0142(197612)38:6<2296::AID-CNCR2820380617>3.0.CO;2-1","article-title":"The immune response at the tumor site in lung carcinoma","volume":"38","author":"Ioachim","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.isci.2026.116029_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4049\/jimmunol.121.1.359","article-title":"Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor","volume":"121","author":"Brodt","year":"1978","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0002-9343(79)91172-0","article-title":"Ovarian cancer: a solid tumor with evidence of normal cellular immune function but abnormal B cell function","volume":"66","author":"Mandell","year":"1979","journal-title":"Am. J. Med."},{"key":"10.1016\/j.isci.2026.116029_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jso.2930320416","article-title":"Colorectal carcinoma in a rat model: suppression of tumour development and altered host immune status following treatment with anti B-lymphocyte serum","volume":"32","author":"House","year":"1986","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.isci.2026.116029_bib28","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s41467-024-55424-2","article-title":"Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms","volume":"16","author":"Sivakumar","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116029_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj4857","article-title":"A blueprint for tumor-infiltrating B cells across human cancers","volume":"384","author":"Ma","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.116029_bib30","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","article-title":"Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation","volume":"16","author":"Mizoguchi","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116029_bib32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116029_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116029_bib34","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116029_bib35","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116029_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105098","article-title":"Intratumoral CD38(+)CD19(+)B cells associate with poor clinical outcomes and immunosuppression in patients with pancreatic ductal adenocarcinoma","volume":"103","author":"Zhu","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.116029_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/2159-8290.CD-15-0843","article-title":"IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia","volume":"6","author":"Pylayeva-Gupta","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.116029_bib38","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1158\/2326-6066.CIR-17-0710","article-title":"IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer","volume":"6","author":"Mirlekar","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2026.116029_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009861","article-title":"B cell c-Maf signaling promotes tumor progression in animal models of pancreatic cancer and melanoma","volume":"12","author":"Zhong","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.116029_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154817","article-title":"Pancreatic cancer-associated inflammation drives dynamic regulation of p35 and Ebi3","volume":"125","author":"Michaud","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.isci.2026.116029_bib41","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1038\/s41388-018-0668-3","article-title":"BTK signaling drives CD1d(hi)CD5(+) regulatory B-cell differentiation to promote pancreatic carcinogenesis","volume":"38","author":"Das","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.116029_bib42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-022-05254-3","article-title":"STING-induced regulatory B cells compromise NK function in cancer immunity","volume":"610","author":"Li","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116029_bib43","article-title":"B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer","volume":"12","author":"Michaud","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/2326-6066.CIR-19-0349","article-title":"B cell-Derived IL35 Drives STAT3-Dependent CD8(+) T-cell Exclusion in Pancreatic Cancer","volume":"8","author":"Mirlekar","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2026.116029_bib45","article-title":"Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity","volume":"3","author":"Mirlekar","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2026.116029_bib46","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","article-title":"IgA transcytosis and antigen recognition govern ovarian cancer immunity","volume":"591","author":"Biswas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116029_bib47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13059-020-02064-6","article-title":"Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer","volume":"21","author":"Chen","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2026.116029_bib48","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccell.2023.02.017","article-title":"B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity","volume":"41","author":"Laumont","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib49","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41591-018-0309-y","article-title":"Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG","volume":"25","author":"Gu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.116029_bib50","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ccr.2014.04.026","article-title":"B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas","volume":"25","author":"Affara","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib51","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fonc.2018.00384","article-title":"KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer","volume":"8","author":"Meng","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.116029_bib52","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41571-025-01019-9","article-title":"Improving outcomes of patients with pancreatic cancer","volume":"22","author":"Dreyer","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116029_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.730746","article-title":"Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features","volume":"12","author":"Pineda","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib54","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172449","article-title":"Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies against self-antigens","volume":"8","author":"Yao","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2026.116029_bib55","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1794359","article-title":"B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma","volume":"9","author":"Minici","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.isci.2026.116029_bib56","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116029_bib57","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.3389\/fimmu.2018.02660","article-title":"Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced in situ by Tumor-Infiltrating B Cells in Breast Cancer","volume":"9","author":"Garaud","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib58","article-title":"The role of interleukin-17 in inflammation-related cancers","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ccell.2023.12.006","article-title":"Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation","volume":"42","author":"Chandra","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00018-024-05268-2","article-title":"CD200R activation on na\u00efve T cells by B cells induces suppressive activity of T cells via IL-24","volume":"81","author":"Chu","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2026.116029_bib61","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ni.1637","article-title":"A critical function for CD200 in lung immune homeostasis and the severity of influenza infection","volume":"9","author":"Snelgrove","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.582657","article-title":"Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer","volume":"11","author":"Shang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib63","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/1440-1681.13317","article-title":"Characterization of B cell-mediated PD-1\/PD-L1 interaction in pancreatic cancer patients","volume":"47","author":"Tong","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.isci.2026.116029_bib64","article-title":"Cancer-associated fibroblast-related prognostic signature predicts prognosis and immunotherapy response in pancreatic adenocarcinoma based on single-cell and bulk RNA-sequencing","volume":"13","author":"Chen","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116029_bib65","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.pan.2023.10.021","article-title":"A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation","volume":"23","author":"Xu","year":"2023","journal-title":"Pancreatology"},{"key":"10.1016\/j.isci.2026.116029_bib66","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.21037\/jgo-23-301","article-title":"A bioinformatics analysis and an experimental validation of the hypoxia-related prognostic model","volume":"14","author":"Zhou","year":"2023","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.isci.2026.116029_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216981","article-title":"Unraveling pancreatic ductal adenocarcinoma immune prognostic signature through a naive B cell gene set","volume":"594","author":"Zhang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.116029_bib68","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.pan.2024.08.014","article-title":"The tumor immune microenvironment in resected treatment-naive pancreatic cancer patients with long-term survival","volume":"24","author":"van Eijck","year":"2024","journal-title":"Pancreatology"},{"key":"10.1016\/j.isci.2026.116029_bib69","article-title":"Discovering a Four-Gene Prognostic Model Based on Single-Cell Data and Gene Expression Data of Pancreatic Adenocarcinoma","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2026.116029_bib70","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/gutjnl-2019-319912","article-title":"Interleukin-1\u03b2-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression","volume":"70","author":"Takahashi","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.isci.2026.116029_bib71","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1158\/2159-8290.CD-19-0620","article-title":"Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma","volume":"10","author":"Muthalagu","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.116029_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153678","article-title":"Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21","volume":"13","author":"Lin","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2026.116029_bib73","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.2174\/1386207326666230314112238","article-title":"Hypoxia-induced Long Non-coding RNA LSAMP-AS1 Regulates ceRNA Network to Predict Prognosis for Pancreatic Cancer","volume":"26","author":"Li","year":"2023","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.isci.2026.116029_bib74","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1158\/2159-8290.CD-15-0822","article-title":"Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia","volume":"6","author":"Lee","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.116029_bib75","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1158\/2326-6066.CIR-18-0517","article-title":"A Transcriptionally Distinct CXCL13(+)CD103(+)CD8(+) T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer","volume":"7","author":"Workel","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2026.116029_bib76","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","article-title":"Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.116029_bib77","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib78","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/2767-9764.CRC-24-0298","article-title":"Depletion of Adipose Stroma-Like Cancer-Associated Fibroblasts Potentiates Pancreatic Cancer Immunotherapy","volume":"5","author":"Rupert","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.isci.2026.116029_bib79","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/0008-5472.CAN-19-2080","article-title":"Tumor Cell-Derived IL1\u03b2 Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer","volume":"80","author":"Das","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.116029_bib80","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00535-023-02020-8","article-title":"A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma","volume":"58","author":"Ashina","year":"2023","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.isci.2026.116029_bib81","article-title":"Spatial genomics reveals a high number and specific location of B cells in the pancreatic ductal adenocarcinoma microenvironment of long-term survivors","volume":"13","author":"Aziz","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib82","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.01229-24","article-title":"Association of tumor microbiome with survival in resected early-stage PDAC","volume":"10","author":"Meng","year":"2025","journal-title":"mSystems"},{"key":"10.1016\/j.isci.2026.116029_bib83","doi-asserted-by":"crossref","first-page":"14803","DOI":"10.18632\/oncotarget.22976","article-title":"Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1\/PD-L1 pathway","volume":"9","author":"Zhao","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.116029_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104819","article-title":"Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE(2)-dependent IgE inhibition in pancreatic cancer","volume":"97","author":"De Monte","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.116029_bib85","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1136\/gutjnl-2022-328697","article-title":"Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas","volume":"72","author":"Kinker","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.isci.2026.116029_bib86","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.116029_bib87","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1158\/2326-6066.CIR-16-0322","article-title":"T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma","volume":"5","author":"Stromnes","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2026.116029_bib88","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI71611","article-title":"Lymphatic vessels and tertiary lymphoid organs","volume":"124","author":"Ruddle","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.isci.2026.116029_bib89","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.116029_bib90","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1158\/0008-5472.CAN-12-1912","article-title":"T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion","volume":"72","author":"Hindley","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.116029_bib91","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1158\/2326-6066.CIR-17-0131","article-title":"Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction","volume":"5","author":"Colbeck","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2026.116029_bib92","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","article-title":"IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer","volume":"638","author":"Amisaki","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116029_bib93","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2016.00407","article-title":"Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention","volume":"7","author":"Saut\u00e8s-Fridman","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib94","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.116029_bib95","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4049\/jimmunol.2000873","article-title":"Tertiary Lymphoid Structures: Diversity in Their Development, Composition, and Role","volume":"206","author":"Gago da Gra\u00e7a","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib96","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cell.2020.03.034","article-title":"Roadmap for the Emerging Field of Cancer Neuroscience","volume":"181","author":"Monje","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116029_bib97","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","article-title":"Cancer hallmarks intersect with neuroscience in the tumor microenvironment","volume":"41","author":"Hanahan","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030490","article-title":"Nerve Fibers in the Tumor Microenvironment Are Co-Localized with Lymphoid Aggregates in Pancreatic Cancer","volume":"10","author":"Heij","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.isci.2026.116029_bib99","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.ccell.2025.06.020","article-title":"Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00535-022-01939-8","article-title":"Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma","volume":"58","author":"Tanaka","year":"2023","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.isci.2026.116029_bib101","article-title":"Investigating the correlation between tertiary lymphoid structures and clinical outcomes in pancreatic ductal adenocarcinoma: insights into tumor immunology","volume":"15","author":"Hu","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.116029_bib102","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1158\/1078-0432.CCR-17-3401","article-title":"Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic\/Predictive Significance","volume":"24","author":"Wartenberg","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116029_bib103","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41379-019-0291-z","article-title":"Characterization of spatial distribution of tumor-infiltrating CD8(+) T cells refines their prognostic utility for pancreatic cancer survival","volume":"32","author":"Masugi","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.isci.2026.116029_bib104","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006698","article-title":"Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance","volume":"11","author":"Zou","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.116029_bib105","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jcmgh.2021.06.023","article-title":"Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice","volume":"12","author":"Delvecchio","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2026.116029_bib106","article-title":"Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer","volume":"10","author":"A","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.isci.2026.116029_bib107","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/cas.14023","article-title":"Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma","volume":"110","author":"Kuwabara","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.isci.2026.116029_bib108","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2027148","article-title":"Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma","volume":"11","author":"Ahmed","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.isci.2026.116029_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.643529","article-title":"Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer","volume":"12","author":"Sadozai","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib110","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41423-020-0457-0","article-title":"Tertiary lymphoid structures in cancer - considerations for patient prognosis","volume":"17","author":"Munoz-Erazo","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib111","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1109\/JBHI.2023.3340686","article-title":"A Weakly Supervised Segmentation Network Embedding Cross-Scale Attention Guidance and Noise-Sensitive Constraint for Detecting Tertiary Lymphoid Structures of Pancreatic Tumors","volume":"28","author":"Wang","year":"2024","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"10.1016\/j.isci.2026.116029_bib112","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00261-021-03285-4","article-title":"Contrast-enhanced computed tomography radiomics and multilayer perceptron network classifier: an approach for predicting CD20(+) B cells in patients with pancreatic ductal adenocarcinoma","volume":"47","author":"Yu","year":"2022","journal-title":"Abdom. Radiol."},{"key":"10.1016\/j.isci.2026.116029_bib113","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.acra.2021.11.013","article-title":"Prediction of Tumor-Infiltrating CD20(+) B-Cells in Patients with Pancreatic Ductal Adenocarcinoma Using a Multilayer Perceptron Network Classifier Based on Non-contrast MRI","volume":"29","author":"Li","year":"2022","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.isci.2026.116029_bib114","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1053\/j.gastro.2015.08.050","article-title":"Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound","volume":"149","author":"Catenacci","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2026.116029_bib115","doi-asserted-by":"crossref","first-page":"E1717","DOI":"10.1055\/a-1264-7206","article-title":"Feasibility and safety study of 22-gauge endoscopic ultrasound (EUS) needles for portal vein sampling in a swine model","volume":"8","author":"Park","year":"2020","journal-title":"Endosc. Int. Open"},{"key":"10.1016\/j.isci.2026.116029_bib116","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004638","article-title":"Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry","volume":"10","author":"Brouwer","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.116029_bib117","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/bjs.10187","article-title":"Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma","volume":"103","author":"Wang","year":"2016","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.isci.2026.116029_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.648917","article-title":"Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma","volume":"12","author":"Tang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051779","article-title":"Upregulation of CD20 Positive B-Cells and B-Cell Aggregates in the Tumor Infiltration Zone is Associated with Better Survival of Patients with Pancreatic Ductal Adenocarcinoma","volume":"21","author":"Brunner","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116029_bib120","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1186\/s12885-023-11738-w","article-title":"Prognostic value of tertiary lymphoid structures (TLS) in digestive system cancers: a systematic review and meta-analysis","volume":"23","author":"Sun","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2026.116029_bib121","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13046-025-03318-6","article-title":"Multiple mechanisms and applications of tertiary lymphoid structures and immune checkpoint blockade","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116029_bib122","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12967-025-06152-8","article-title":"Prognostic implications and characterization of tumor-associated tertiary lymphoid structures genes in pancreatic cancer","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.116029_bib123","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jleuko\/qiae067","article-title":"Integrating tertiary lymphoid structure-associated genes into computational models to evaluate prognostication and immune infiltration in pancreatic cancer","volume":"116","author":"Ma","year":"2024","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.isci.2026.116029_bib124","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7150\/thno.105423","article-title":"B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications","volume":"15","author":"Wu","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.116029_bib125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2022.01.039","article-title":"Nano-trapping CXCL13 reduces regulatory B cells in tumor microenvironment and inhibits tumor growth","volume":"343","author":"Shen","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.116029_bib126","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/2159-8290.CD-15-0827","article-title":"Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives","volume":"6","author":"Gunderson","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.116029_bib127","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2019.07.039","article-title":"Inhibiting PI3 kinase-\u03b3 in both myeloid and plasma cells remodels the suppressive tumor microenvironment in desmoplastic tumors","volume":"309","author":"Zhang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.116029_bib128","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.annonc.2021.01.070","article-title":"Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study","volume":"32","author":"Tempero","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2026.116029_bib129","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3389\/fimmu.2019.00542","article-title":"Discrepancies in the Tumor Microenvironment of Spontaneous and Orthotopic Murine Models of Pancreatic Cancer Uncover a New Immunostimulatory Phenotype for B Cells","volume":"10","author":"Spear","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib130","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/2326-6066.CIR-14-0027","article-title":"Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation","volume":"2","author":"Lutz","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2026.116029_bib131","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ccell.2022.10.001","article-title":"Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib133","doi-asserted-by":"crossref","first-page":"21385","DOI":"10.1021\/acsnano.5c01280","article-title":"Cognate Nanovaccine Promotes Tertiary Lymphoid Structures Function and Strengthens Immune Cell Cross-Talk by Targeting Exhausted T Cells in Nonimmunogenic Cancers","volume":"19","author":"Chen","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.isci.2026.116029_bib132","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/1078-0432.CCR-21-2495","article-title":"Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy","volume":"28","author":"Mills","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116029_bib134","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/j.gastro.2021.12.273","article-title":"Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma","volume":"162","author":"Hosein","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2026.116029_bib135","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1111\/cas.14914","article-title":"The immunological impact of preoperative chemoradiotherapy on the tumor microenvironment of pancreatic cancer","volume":"112","author":"Okubo","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.isci.2026.116029_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1378190","article-title":"Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma","volume":"15","author":"Rupp","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib137","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202217341","article-title":"Functions of double-negative B cells in autoimmune diseases, infections, and cancers","volume":"15","author":"Chung","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2026.116029_bib138","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12967-018-1404-z","article-title":"Double-negative (CD27(-)IgD(-)) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations","volume":"16","author":"Centuori","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.116029_bib139","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41467-021-21795-z","article-title":"Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma","volume":"12","author":"Gong","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116029_bib140","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nri1354","article-title":"Lymphocyte trafficking across high endothelial venules: dogmas and enigmas","volume":"4","author":"Miyasaka","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189312","article-title":"Tertiary lymphoid structures achieve 'cold' to 'hot' transition by remodeling the cold tumor microenvironment","volume":"1880","author":"Cui","year":"2025","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.116029_bib142","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature10540","article-title":"Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules","volume":"479","author":"Moussion","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116029_bib143","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","article-title":"Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1(+) T lymphocyte niches through a feed-forward loop","volume":"40","author":"Hua","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib144","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ccell.2023.04.010","article-title":"Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma","volume":"41","author":"Ramachandran","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109422","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.116029_bib146","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib147","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","article-title":"Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures","volume":"43","author":"Tang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116029_bib148","doi-asserted-by":"crossref","first-page":"9845","DOI":"10.1038\/s41598-025-94664-0","article-title":"Automated classification of tertiary lymphoid structures in colorectal cancer using TLS-PAT artificial intelligence tool","volume":"15","author":"Le Rochais","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116029_bib149","article-title":"Development and Validation of a Machine Learning Model for Detection and Classification of Tertiary Lymphoid Structures in Gastrointestinal Cancers","volume":"6","author":"Li","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.isci.2026.116029_bib150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41698-024-00579-w","article-title":"Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response","volume":"8","author":"Chen","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.isci.2026.116029_bib151","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001906","article-title":"STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment","volume":"9","author":"Chelvanambi","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.116029_bib152","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.immuni.2021.12.007","article-title":"TGF-\u03b2-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures","volume":"55","author":"Chaurio","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116029_bib153","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ni.3836","article-title":"De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors","volume":"18","author":"Johansson-Percival","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.116029_bib154","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.immuni.2021.11.003","article-title":"Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer","volume":"54","author":"Overacre-Delgoffe","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116029_bib155","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1158\/2159-8290.CD-22-0201","article-title":"Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer","volume":"12","author":"Goubet","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.116029_bib156","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","article-title":"Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities","volume":"18","author":"Deng","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.116029_bib157","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00401-017-1802-y","article-title":"Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration","volume":"135","author":"Small","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.isci.2026.116029_bib158","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001188","article-title":"Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors","volume":"8","author":"Zhang","year":"2020","journal-title":"J. Immunother. Cancer"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226014045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226014045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:01:05Z","timestamp":1791838865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226014045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":158,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2589004226014045"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116029","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor infiltrating B cells and tertiary lymphoid structures in pancreatic cancer prognosis and therapy","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116029"}}